Very few shares ended in the red this week, and none were big fallers except BLU:Blue Star Capital which I don't report on due to being down over 90%, but which dropped 19% and gets a mention in the absence of any other big fallers.
ASHM:Ashmore Group went up 5%.
AMRQ:Amaroq, DXRX:Diaceutics, FOUR:4imprint and SOI:Schroder Oriental Income all went up 6%.
CORE:Solidcore Resources and IPX:Impax Asset Management went up 7%.
PAF:Pan African Resources went up 8%.
GGP:Greatland Resources, POLR:Polar Capital and RSW:Renishaw went up 9%.
ATYM:Atalya Mining and FRES:Fresnillo went up 10%.
Share of the Week goes to EDV:Endeavour Mining, which went up 11%. I remember the days when there used to be a reason for big changes in share price over a week, but recently it's been a significant chunk of my portfolio either up or down a huge amount every week for no reason other than a small change in the price of gold or Trump doing something.
Here's the ISA and shares portfolio after week 41 of year 11.
| Weekly Change | |||
| Cash | £117.29 | -£3.32 | |
| Portfolio cost | £116,490.29 | +£0 | |
| Portfolio sell value (bid price-commission) | £31,928.56 | (-72.6%) | +£175.83 |
| Potential profits | £462.25 | +£93.23 | |
| Yr 11 Dividends | £86.83 | +£0 | |
| Yr 11 Interest | £1.40 | +£0 | |
| Yr 11 Profit from sales | £873.14 | +£0 | |
| Yr 11 proj avg monthly profit | £93.76 | (1.3%) | -£2.40 |
| Total Dividends | £12,574.90 | +£0 | |
| Total Interest | £9.97 | +£0 | |
| Total Profit from sales | £18,433.41 | +£0 | |
| Average monthly cash profit | £234.65 | (3.3%) | -£0.44 |
| (Sold stocks profit + Dividends - Fees / Months) |
My biggest holdings were all flat this week, so the increase was pretty muted, but it was heartening that over half the increase was in potential profits, up by £92.
I think the most positive thing I can say is that it's better than last week.
Still below the trend line.
The SIPP looks like this after week 545 overall and week 25 of year 11.
| Weekly Change | ||||
| Cash | £1,016.71 | +£251.27 | ||
| Portfolio cost | £159,043.33 | +£0 | ||
| Portfolio sell value (bid price - commission) | £92,394.34 | (-41.9%) | +£3,186.09 | |
| Potential profits | £13,882.95 | +£2,067.95 | ||
| Yr 11 Dividends | £941.96 | +£13.77 | ||
| Yr 11 Interest | £11.94 | +£0 | ||
| Yr 11 Profit from sales | £9,216.80 | +£0 | ||
| Yr 11 proj avg monthly profit | £1,743.72 | (21.2%) | -£72.42 | |
| Total Dividends | £19,162.16 | +£13.77 | ||
| Total Interest | £32.64 | +£0 | ||
| Total Profit from sales | £33,883.31 | +£0 | ||
| Average monthly cash profit | £408.26 | (5.0%) | -£0.74 |
Cash went up thank to my monthly investment cash going in, and the purchase will be next week. Big increase in value and lots of that was potential profits. Given all my biggest holdings were flat, it's good to see the others can make a significant difference on their own. I had a £13 dividend from BTG:BTG Consulting.
It would be so nice to get past the injection line and stay there, so I can then start focusing on the cost line instead. It's not going to happen until JLP:Jubilee Metals and OPTI:Optibiotix have a turn of fortune. Unfortunately there's no sign of that ever happening.
Still below the trend line, but only just.
It had to happen one day, we've hit the trend line and will dip below it next week. I fear it will now drift until August when I re-calculate the magic formula rankings and have a big sell-off.
No comments:
Post a Comment